Literature DB >> 33727627

Thermolabile drug storage in an ambulatory setting.

Fernando do Pazo-Oubiña1, Bartomeu Alorda-Ladaria2,3, Ana Gomez-Lobon4, Bàrbara Boyeras-Vallespir4, María Margalida Santandreu-Estelrich4, Clara Martorell-Puigserver4, María Gomez-Zamora4, Pere Ventayol-Bosch4, Olga Delgado-Sanchez4.   

Abstract

More thermolabile drugs are becoming available, and in most cases, these medications are dispensed to ambulatory patients. However, there is no regulation once medications are dispensed to patients and little is known with regard to what happens during transport and home storage. Previous studies suggest that these drugs are improperly stored. The present study was designed to determine the storage conditions of thermolabile drugs once they are dispensed to the patient in the Hospital Pharmacy Department. This is a prospective observational study to assess the temperature profile of 7 thermolabile drugs once they are dispensed to ambulatory patients at a tertiary care hospital. A data logger was added to the medication packaging. Temperature was considered inappropriate if one of the following circumstances were met: any temperature record less than or equal to 0 °C or over 25 °C; temperatures between 0-2 or 8-25 °C for a continuous period over 30 min. The time series of temperature measurements obtained from each data logger were analyzed as statistically independent variables. The data shown did not undergo any statistical treatment and must be considered directly related to thermal measurements. One hundred and fourteen patients were included and 107 patients were available for the analysis. On the whole, a mean of 50.6 days (SD 18.3) were measured and the mean temperature was 6.88 °C (SD 2.93). Three data loggers (2.8%) maintained all the measurements between 2 and 8 °C with less than 3 continuous data (< 30 min) out of this range but no data over 25 °C or below or equal to 0 °C. 28 (26.2%) data loggers had at least one measurement below zero, 1 data logger had a measurement greater than 25 °C and 75 (70.1%) were between 0 and 2 °C and/or between 8 and 25 °C for more than 30 min. In conclusion, once dispensed to patients, most thermolabile drugs are improperly stored. Future studies should focus on clinical consequences and possible solutions.

Entities:  

Year:  2021        PMID: 33727627      PMCID: PMC7966808          DOI: 10.1038/s41598-021-85413-0

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  8 in total

1.  [Quality of storage of thermolabile drugs in patients' homes].

Authors:  M J Cuéllar; J L Marco; I Pérez-Castelló; A Castelló Escrivá
Journal:  Rev Calid Asist       Date:  2009-11-01

2.  Exploring conditions for redistribution of anti-tumor necrosis factors to reduce spillage: A study on the quality of anti-tumor necrosis factor home storage.

Authors:  Marin J de Jong; Marieke J Pierik; Andy Peters; Mark Roemers; Veronique Hilhorst; Astrid van Tubergen
Journal:  J Gastroenterol Hepatol       Date:  2018-02       Impact factor: 4.029

3.  [Thermolabile drugs stability faced with an accidental interruption in the cold chain].

Authors:  I Ricote-Lobera; B Ortiz-Martín; S Fraile-Gil; B Santos-Mena; F J Hidalgo-Correas; B García-Díaz
Journal:  Farm Hosp       Date:  2014-05-01

4.  Domestic refrigerator temperatures in Spain: Assessment of its impact on the safety and shelf-life of cooked meat products.

Authors:  Anna Jofré; Mari Luz Latorre-Moratalla; Margarita Garriga; Sara Bover-Cid
Journal:  Food Res Int       Date:  2019-07-22       Impact factor: 6.475

5.  Storage Conditions of Insulin in Domestic Refrigerators and When Carried by Patients: Often Outside Recommended Temperature Range.

Authors:  Katarina Braune; Laura A Kraemer; Jeremias Weinstein; Amin Zayani; Lutz Heinemann
Journal:  Diabetes Technol Ther       Date:  2019-04-19       Impact factor: 6.118

Review 6.  Protein aggregation and its impact on product quality.

Authors:  Christopher J Roberts
Journal:  Curr Opin Biotechnol       Date:  2014-08-28       Impact factor: 9.740

7.  The majority of patients do not store their biologic disease-modifying antirheumatic drugs within the recommended temperature range.

Authors:  Nicolaas D Vlieland; Helga Gardarsdottir; Marcel L Bouvy; Toine C G Egberts; Bart J F van den Bemt
Journal:  Rheumatology (Oxford)       Date:  2015-12-16       Impact factor: 7.580

8.  The Impact of Inadequate Temperature Storage Conditions on Aggregate and Particle Formation in Drugs Containing Tumor Necrosis Factor-Alpha Inhibitors.

Authors:  N D Vlieland; M R Nejadnik; H Gardarsdottir; S Romeijn; A S Sediq; M L Bouvy; A C G Egberts; B J F van den Bemt; W Jiskoot
Journal:  Pharm Res       Date:  2018-02-05       Impact factor: 4.200

  8 in total
  1 in total

Review 1.  Polymer-Based Nanofiber-Nanoparticle Hybrids and Their Medical Applications.

Authors:  Mingxin Zhang; Wenliang Song; Yunxin Tang; Xizi Xu; Yingning Huang; Dengguang Yu
Journal:  Polymers (Basel)       Date:  2022-01-17       Impact factor: 4.329

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.